Abbott Laboratories (ABT) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Industry, else..
 
Abbott Laboratories  (NYSE: ABT)
 

Abbott Laboratories Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABT Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 7.78 % 12.22 % 8.91 % 10.9 %
Q / Q Revenue Growth (Q1 MRQ) -2.57 % -2.93 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) 6.59 % 9.25 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) 1.82 % 2.69 % 2.03 % 2.61 %
Revenue 5 Year Average Growth 5.08 % 7.41 % 8.65 % 10.59 %


ABT's Growth Comparisons in I. Quarter 2026




Comparing 7.78% year on year top-line growth in the first quarter 2026, Abbott Laboratories grew on the lower pace than the 12.22% rise in the Major Pharmaceutical Preparations industry and 8.91% Revenue growth in the Healthcare sector. Comparing the first quarter, sales Abbott Laboratories was trailing overall market not just Major Pharmaceutical Preparations industry.

Top-line fell by -2.57% from the fourth quarter. Average annual sales growth for Abbott Laboratories is 5.08%, while S & P 500's average yearly sales increase is 10.59%, including only Businesses with the first quarter 2026 financial results.

ABT Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
United States
2.54 %
-
International
11.31 %
-
Established Pharmaceuticals
13.17 %
-
Established Pharmaceuticals Key Emerging Markets
12.85 %
-
Established Pharmaceuticals Other
14.24 %
-
Nutritional Products
-6.01 %
-
Nutritional Products Pediatric Nutritionals
-8.45 %
-
Nutritional Products Adult Nutritionals
-3.71 %
-
Diagnostic Products
6.13 %
-
Diagnostic Products Core Laboratory
8.07 %
-
Diagnostic Products Rapid and Molecular
-7.41 %
-
Diagnostic Products Cancer Diagnostics
-
-
Medical Devices
13.16 %
-
Medical Devices Rhythm Management
16.92 %
-
Medical Devices Electrophysiology
16.74 %
-
Medical Devices Heart Failure
14.75 %
-
Medical Devices Vascular
9.44 %
-
Medical Devices Structural Heart
8.85 %
-
Medical Devices Neuromodulation
6.58 %
-
Medical Devices Diabetes Care
13.85 %
-
United States Nutritional Products
-11.62 %
-
United States Nutritional Products Pediatric Nutritionals
-13.1 %
-
United States Nutritional Products Adult Nutritionals
-9.26 %
-
United States Diagnostic Products
3.9 %
-
United States Diagnostic Products Core Laboratory
4.52 %
-
United States Diagnostic Products Rapid and Molecular
-13.73 %
-
United States Diagnostic Products Cancer Diagnostics
-
-
United States Medical Devices
7.87 %
-
United States Medical Devices Rhythm Management
11.51 %
-
United States Medical Devices Electrophysiology
13.51 %
-
United States Medical Devices Heart Failure
11.45 %
-
United States Medical Devices Vascular
8.58 %
-
United States Medical Devices Structural Heart
-9.68 %
-
United States Medical Devices Neuromodulation
0.57 %
-
United States Medical Devices Diabetes Care
9.89 %
-
International Established Pharmaceuticals
13.17 %
-
International Established Pharmaceuticals Key Emerging Markets
12.85 %
-
International Established Pharmaceuticals Other
14.24 %
-
International Nutritional Products
-1.51 %
-
International Nutritional Products Pediatric Nutritionals
-2.43 %
-
International Nutritional Products Adult Nutritionals
-0.95 %
-
International Diagnostic Products
7.78 %
-
International Diagnostic Products Core Laboratory
9.47 %
-
International Diagnostic Products Rapid and Molecular
2.66 %
-
International Diagnostic Products Cancer Diagnostics
-
-
International Medical Devices
18 %
-
International Medical Devices Rhythm Management
22.78 %
-
International Medical Devices Electrophysiology
19.88 %
-
International Medical Devices Heart Failure
25.97 %
-
International Medical Devices Vascular
9.95 %
-
International Medical Devices Structural Heart
25.09 %
-
International Medical Devices Neuromodulation
26.92 %
-
International Medical Devices Diabetes Care
16.59 %
-
Other
-33.33 %
-
Other United States
-33.33 %
-
Total
7.78 %
-


Growth Rates of ABT's Income in the first quarter 2026


ABT Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) -20.56 % -8.88 % 4.62 % 97.6 %
Sequential Operating Income Change (Q1 MRQ) -40.25 % -4.52 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q1 TTM) 8.03 % 30.63 % 30.73 % 40.67 %
Sequential Operating Income Growth (Q1 TTM) -4.32 % -2.27 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change 8.49 % 14.39 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) -18.72 % -34.9 % -25.98 % 90.69 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) -55.88 % -2.61 % -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) -49.57 % 6.3 % 2.68 % 57.33 %
Sequential Income from Cont. Ops. Change (Q1 TTM) -3.45 % -10.02 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change 7.85 % -0.55 % 0.17 % -28.52 %

ABT Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) -18.72 % -35.09 % -26.26 % 90.69 %
Q / Q Net Income Growth (Q1 MRQ) -39.36 % 2.87 % -0.77 % 27.07 %
Y / Y Net Income Change (Q1 TTM) -53.52 % 5.21 % 15.51 % 57.33 %
Sequential Net Income Change (Q1 TTM) -3.8 % -10.17 % -6.72 % 18.65 %
Net Income 5 Year Avg. Growth 7.74 % 14.55 % 9.21 % 22.96 %

ABT's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) -18.42 % -40.27 % -25.98 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) -39.81 % -7.72 % -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) -53.48 % - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) -3.73 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 8.24 % -10.78 % 0.17 % -28.52 %



ABT EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) -19.74 % -40.45 % -26.26 % -28.52 %
Q / Q EPS Net Growth (Q1 MRQ) -40.78 % -2.53 % -0.77 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) -4.01 % - - 4.93 %
EPS Net 5 Year Avg. Change 8.27 % 14.55 % 9.21 % 22.96 %



Abbott Laboratories reported -19.74% year on year EPS decline in the first quarter, and Major Pharmaceutical Preparations industry with -40.45%, and less than -26.26% slide in the Healthcare sector. Slow first quarter 2026 income per share in Major Pharmaceutical Preparations industry and Healthcare sector, were portrayed in Abbott Laboratories's results, which underperformed overall market.

Bottom-line fell by -40.78% from the fourth quarter results. Comparing the annual growth, income per share of 8.27% on average in last five years, to the S & P 500's, including only Businesses with the first quarter 2026 earnings, average yearly income per share growth is 22.96%. Abbott Laboratories grew less than the market.

ABT Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) -1.82 % 25.53 % 48.49 % 48.62 %
Sequential Free Cash Flow Change (Q1 MRQ) -65.12 % -42.37 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q1 TTM) 10.83 % 11.91 % 18.61 % 60.27 %
Sequential Free Cash Flow Change (Q1 TTM) -0.23 % 3.24 % 5.39 % 15.75 %
Free Cash Flow 5 Year Avg. Change 5.26 % 1.86 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q1 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q1 TTM) 9.27 % - - 209.43 %
Sequential Net Cash Flow Change (Q1 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change -21.18 % 29.88 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -17.56 % 11.25 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q1 MRQ) -42.09 % -25.6 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q1 TTM) -9.03 % 16.65 % 7.87 % 109.38 %
Sequential Capital Expenditures Change (Q1 TTM) -3.92 % 2.92 % 1.6 % 23.05 %
Capital Expenditures 5 Year Avg. Change -0.06 % 8.82 % 9.12 % 14.73 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.